Literature DB >> 28027041

Effectiveness of Occupational Therapy Interventions for Adults With Fibromyalgia: A Systematic Review.

Janet L Poole1, Patricia Siegel2.   

Abstract

OBJECTIVE: This systematic review addresses the effectiveness of occupational therapy-related interventions for adults with fibromyalgia.
METHOD: We examined the literature published between January 2000 and June 2014. A total of 322 abstracts from five databases were reviewed. Forty-two Level I studies met the inclusion criteria. Studies were evaluated primarily with regard to the following outcomes: daily activities, pain, depressive symptoms, fatigue, and sleep.
RESULTS: Strong evidence was found for interventions categorized for this review as cognitive-behavioral interventions; relaxation and stress management; emotional disclosure; physical activity; and multidisciplinary interventions for improving daily living, pain, depressive symptoms, and fatigue. There was limited to no evidence for self-management, and few interventions resulted in better sleep.
CONCLUSION: Although the evidence supports interventions within the scope of occupational therapy practice for people with fibromyalgia, few interventions were occupation based.
Copyright © 2017 by the American Occupational Therapy Association, Inc.

Entities:  

Mesh:

Year:  2017        PMID: 28027041     DOI: 10.5014/ajot.2017.023192

Source DB:  PubMed          Journal:  Am J Occup Ther        ISSN: 0272-9490


  3 in total

1.  Patients' experiences of occupational therapy within a multidisciplinary pain management programme: A qualitative study.

Authors:  Jacqueline Goodall; Terence Brown
Journal:  Br J Pain       Date:  2021-12-07

Review 2.  Occupational Therapy's Unique Contribution to Chronic Pain Management: A Scoping Review.

Authors:  Émilie Lagueux; Andréa Dépelteau; Julie Masse
Journal:  Pain Res Manag       Date:  2018-11-12       Impact factor: 3.037

3.  An Association Rule Analysis of the Acupressure Effect on Sleep Quality.

Authors:  Chih-Hung Lin; Ya-Hsuan Lin; I-Shiang Tzeng; Chan-Yen Kuo
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-29       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.